AU5432690A
(en)
*
|
1989-03-31 |
1990-11-05 |
Washington University |
Bordetella vaccines
|
JPH06501847A
(ja)
*
|
1990-10-25 |
1994-03-03 |
コモンウェルス サイエンティフィク アンド インダストリアルリサーチ オーガナイゼイション |
ワクチンベクターとしてのコリネバクテリウム及び関連する生物
|
US5637303A
(en)
*
|
1990-10-25 |
1997-06-10 |
Commonwealth Scientific And Industrial Research Organisation |
Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination
|
JP3601602B2
(ja)
*
|
1990-11-09 |
2004-12-15 |
ワシントン ユニバーシティ |
無毒性微生物及びその使用:サルモネラ
|
US5599537A
(en)
*
|
1990-12-18 |
1997-02-04 |
The General Hospital Corporation |
Salmonella virulence genes
|
US5843426A
(en)
*
|
1990-12-18 |
1998-12-01 |
The General Hospital Corporation |
Salmonella vaccines
|
US5587305A
(en)
*
|
1993-12-06 |
1996-12-24 |
The United States Of America As Represented By The Department Of Agriculture |
Pasteurella haemolytica transformants
|
US6793927B1
(en)
|
1993-12-06 |
2004-09-21 |
The United States Of America As Represented By The Secretary Of The Department Of Agriculture |
Construction of Pasteurella haemolytica vaccines
|
US5922583A
(en)
*
|
1995-10-17 |
1999-07-13 |
Biostar Inc. |
Methods for production of recombinant plasmids
|
US5925354A
(en)
*
|
1995-11-30 |
1999-07-20 |
Michigan State University |
Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
|
US20030202980A1
(en)
*
|
1995-12-29 |
2003-10-30 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
ZA97452B
(en)
*
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
GB9615022D0
(en)
*
|
1996-07-17 |
1996-09-04 |
Mini Agriculture & Fisheries |
Vaccine preparations
|
US6020144A
(en)
|
1996-09-12 |
2000-02-01 |
Symbiontics, Inc. |
Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
|
CA2243730C
(en)
*
|
1997-07-29 |
2009-12-22 |
Akzo Nobel N.V. |
Streptococcus equi vaccine
|
WO1999018221A1
(en)
|
1997-10-07 |
1999-04-15 |
University Of Maryland Biotechnology Institute |
Method for introducing and expressing rna in animal cells
|
US6024961A
(en)
|
1997-11-14 |
2000-02-15 |
Washington University |
Recombinant avirulent immunogenic S typhi having rpos positive phenotype
|
AU743647B2
(en)
|
1998-01-31 |
2002-01-31 |
Mt. Sinai School Of Medicine Of New York University |
Methods and reagents for decreasing allergic reactions
|
US7879977B2
(en)
|
1998-01-31 |
2011-02-01 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
CA2792479A1
(en)
|
1998-02-27 |
1999-09-02 |
The Trustees Of The University Of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
US6713073B1
(en)
*
|
1998-07-24 |
2004-03-30 |
Megan Health, Inc. |
Method of vaccination of newly hatched poultry
|
JP2002531135A
(ja)
*
|
1998-12-04 |
2002-09-24 |
ユニヴァーシティ オブ マニトーバ |
クラミジア感染に対する2段階免疫感作法
|
BR0008645A
(pt)
*
|
1999-03-03 |
2002-01-22 |
Univ Pennsylvania |
Métodos de induzir uma resposta imunológica contra um imunógeno em um indivìduo, de reduzir rejeição de células, tecido ou órgão doadores nã0-assemelhados em um indivìduo e uma resposta imunológica dominante em um indivìduo e de expandir uma subpopulação de células t associadas com uma resposta imunológica especìfica, plasmìdeo, e, composição
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
EP1860117A3
(en)
|
1999-04-09 |
2008-09-03 |
Pharmacia & Upjohn Company LLC |
Anti-bacterial vaccine compositions
|
WO2000066162A1
(en)
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
US8153414B2
(en)
|
2000-04-06 |
2012-04-10 |
Allertein Therapeutics, Llc |
Microbial delivery system
|
US20050063994A1
(en)
*
|
2000-04-06 |
2005-03-24 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
US6780405B1
(en)
*
|
2000-04-28 |
2004-08-24 |
Avant Immunotherapeutics, Inc. |
Regulated antigen delivery system (RADS)
|
AU2001283493B2
(en)
*
|
2000-07-14 |
2006-11-30 |
The Trustees Of The University Of Pennsylvania |
DNA vaccines encoding HIV accessory proteins
|
CA2425152A1
(en)
*
|
2000-10-04 |
2002-04-11 |
The Trustees Of The University Of Pennsylvania |
Highly expressible genes
|
US6872547B1
(en)
|
2000-10-11 |
2005-03-29 |
Washington University |
Functional balanced-lethal host-vector systems
|
US20040137003A1
(en)
*
|
2001-04-30 |
2004-07-15 |
Curtiss Iii Roy |
Regulated antigen delivery system (rads)
|
ATE556596T1
(de)
*
|
2002-04-15 |
2012-05-15 |
Univ St Louis |
Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
EP1633372B1
(en)
|
2003-06-13 |
2011-11-30 |
The Trustees of The University of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
EP1691615A2
(en)
*
|
2003-12-09 |
2006-08-23 |
Avant Immunotherapeutics, Inc. |
Orally-administered live bacterial vaccines for plague
|
US20080274140A1
(en)
*
|
2004-11-19 |
2008-11-06 |
David B Weiner |
Vaccines and Methods for Using the Same
|
ATE533782T1
(de)
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
WO2007106073A2
(en)
|
2006-03-02 |
2007-09-20 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
EP2049559B1
(en)
|
2006-07-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Improved hpv vaccines
|
US20080124355A1
(en)
|
2006-09-22 |
2008-05-29 |
David Gordon Bermudes |
Live bacterial vaccines for viral infection prophylaxis or treatment
|
EP2150616A4
(en)
|
2007-05-10 |
2011-07-27 |
Univ Arizona |
REGULATED ANTIGEN SYNTHESIS AND / OR REGULATED ATTENUATION FOR IMPROVING VACCINATE IMMUNOGENICITY AND / OR SAFETY
|
EP2152883A4
(en)
*
|
2007-05-10 |
2010-10-27 |
Univ Arizona |
RECOMBINANT BACTERIA COMPRISING VECTORS FOR THE EXPRESSION OF NUCLEIC ACID SEQUENCES ENCODING ANTIGENS
|
WO2009046451A1
(en)
|
2007-10-05 |
2009-04-09 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting a protective immune response against c. perfringens
|
KR101589511B1
(ko)
*
|
2008-04-04 |
2016-02-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
치쿤구니야 바이러스 단백질의 공통 서열, 이를 인코딩하는 핵산 분자, 조성물 및 이를 이용하는 방법
|
CN102016023A
(zh)
|
2008-04-04 |
2011-04-13 |
宾夕法尼亚州立大学托管会 |
使用il-28和组合物的疫苗和免疫治疗及其使用方法
|
US8647642B2
(en)
|
2008-09-18 |
2014-02-11 |
Aviex Technologies, Llc |
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
|
WO2010045620A1
(en)
|
2008-10-17 |
2010-04-22 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US8829174B2
(en)
|
2008-10-29 |
2014-09-09 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
EP2411513B1
(en)
*
|
2009-03-23 |
2016-11-09 |
Institut Pasteur |
MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
|
US9163219B2
(en)
|
2009-04-14 |
2015-10-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Single expression vector for generation of a virus with a segmented genome
|
WO2010135563A1
(en)
|
2009-05-22 |
2010-11-25 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium and methods of antigen and nucleic acid delivery
|
US9045742B2
(en)
|
2009-05-29 |
2015-06-02 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant Edwardsiella bacterium
|
KR20120093163A
(ko)
|
2009-09-14 |
2012-08-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법
|
CN106987595B
(zh)
|
2009-11-02 |
2021-07-06 |
宾夕法尼亚大学托管会 |
***病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗
|
US9062297B2
(en)
|
2010-01-13 |
2015-06-23 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Yersinia pestis vaccine
|
US8889121B2
(en)
|
2010-01-22 |
2014-11-18 |
The Arizona Board Of Regents For An On Behalf Of Arizona State University |
Bacterium comprising a regulated rfaH nucleic acid
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
KR101784177B1
(ko)
|
2010-02-08 |
2017-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Rantes를 암호화하는 핵산 분자, 그리고 이를 포함하는 조성물 및 이의 사용 방법
|
WO2011150421A2
(en)
|
2010-05-28 |
2011-12-01 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium to decrease tumor growth
|
US9255283B2
(en)
|
2010-07-02 |
2016-02-09 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Compositions and methods for bacterial lysis and neutral lipid production
|
BRPI1003750A2
(pt)
|
2010-07-22 |
2012-04-10 |
Univ Sao Paulo |
microrganismos recombinantes, métodos de preparação de linhagens vacinais, antìgenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia
|
KR102131276B1
(ko)
|
2010-11-12 |
2020-07-08 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
공통 전립선 항원, 이것을 암호화하는 핵산 분자, 그리고 이것을 포함하는 백신 및 용도
|
CN102140430B
(zh)
*
|
2011-01-13 |
2013-10-23 |
河南科技大学 |
一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
|
JP6099573B2
(ja)
|
2011-01-31 |
2017-03-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法
|
MX343830B
(es)
|
2011-02-11 |
2016-11-24 |
Univ Pennsylvania |
Molecula de acido nucleico que codifica la proteina nuclear del virus de la hepatitis b y vacuna que comprende la misma.
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
WO2012123269A1
(en)
|
2011-03-11 |
2012-09-20 |
Proyecto De Biomedicina Cima, S.L. |
Immunogenic compositions and methods for their use
|
KR102071228B1
(ko)
|
2011-07-11 |
2020-01-30 |
이노비오 파마수티컬즈, 인크. |
교차-보호성 아레나바이러스 백신 및 이의 사용 방법
|
KR20140076613A
(ko)
|
2011-10-12 |
2014-06-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
WO2013062507A1
(en)
|
2011-10-24 |
2013-05-02 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用
|
US9272024B2
(en)
|
2011-12-12 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
|
WO2013155205A1
(en)
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
US9303264B2
(en)
|
2012-05-18 |
2016-04-05 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Photosynthetic microorganisms expressing thermostable lipase
|
KR101381793B1
(ko)
|
2013-02-27 |
2014-04-07 |
씨제이제일제당 (주) |
신규 박테리오파지 및 이를 포함하는 항균 조성물
|
WO2014165291A1
(en)
|
2013-03-12 |
2014-10-09 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines for human papilloma virus and methods for using the same
|
CA2895806C
(en)
|
2013-03-15 |
2023-02-21 |
The Trustees Of The University Of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
US11419925B2
(en)
|
2013-03-15 |
2022-08-23 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
US9580718B2
(en)
|
2013-06-17 |
2017-02-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Attenuated live bacteria with increased acid resistance and methods of use thereof
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
CA3084135C
(en)
|
2017-12-13 |
2024-03-05 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting muc16 and uses thereof
|
RU2748903C1
(ru)
|
2017-12-13 |
2021-06-01 |
Иновио Фармасьютикалз, Инк. |
Противораковые вакцины, нацеленные на prame, и их применения
|
US11154602B2
(en)
|
2017-12-13 |
2021-10-26 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting mesothelin and uses thereof
|